Actimmune

DRUG2 trials

Sponsors

Rockefeller University, Indiana University

Conditions

Autosomal Dominant Osteopetrosis Type 2Plaque Psoriasis

Early Phase 1

Cell Responses to IFN-gamma

TerminatedNCT01317017

Rockefeller UniversityPlaque Psoriasis

Start: 2010-07-31End: 2011-05-31Updated: 2013-03-05

Phase 2

Use of ACTIMMUNE in Patients With ADO2

CompletedNCT02584608

Indiana UniversityAutosomal Dominant Osteopetrosis Type 2

Start: 2016-01-01End: 2019-11-12Updated: 2021-01-08